ViatrisVTRSEarnings & Financial Report
Viatris Inc. is an American global pharmaceutical and healthcare corporation headquartered in Canonsburg, Pennsylvania. The corporation was formed through the merger of Mylan and Upjohn, a legacy division of Pfizer, on November 16, 2020.
VTRS Q3 2025 Key Financial Metrics
营收
$3.7B
毛利润
$1.4B
营业利润
$178.8M
净利润
N/A
毛利率
36.6%
营业利润率
4.8%
净利率
N/A
同比增长
0.3%
EPS
$-0.11
资金流向
Viatris Q3 2025 Financial Summary
Viatris reported revenue of $3.7B for Q3 2025, with a net profit of N/A (N/A margin). Cost of goods sold was $2.4B, operating expenses totaled $1.2B.
Key Financial Metrics
| Total Revenue | $3.7B |
|---|---|
| Net Profit | N/A |
| Gross Margin | 36.6% |
| Operating Margin | 4.8% |
| Report Period | Q3 2025 |
Viatris Annual Revenue by Year
Viatris annual revenue history includes year-by-year totals (for example, 2024 revenue was $14.7B).
| Year | Annual Revenue |
|---|---|
| 2024 | $14.7B |
| 2023 | $15.4B |
| 2022 | $16.2B |
利润表
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| 营收 | $3.83B | $3.65B | $3.79B | $3.74B | $3.52B | $3.24B | $3.57B | $3.75B |
| 同比增长 | -1.1% | -1.8% | -3.2% | -5.0% | -8.1% | -11.2% | -5.7% | 0.3% |
资产负债表
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| 总资产 | $47.69B | $47.34B | $45.33B | $44.75B | $41.50B | $38.47B | $38.41B | $37.92B |
| 总负债 | $27.22B | $27.33B | $25.81B | $24.96B | $22.87B | $22.82B | $22.84B | $22.70B |
| 股东权益 | $20.47B | $20.01B | $19.52B | $19.79B | $18.64B | $15.65B | $15.57B | $15.22B |
现金流量表
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| 经营性现金流 | $479.4M | $614.6M | $379.1M | $826.5M | $482.7M | $535.5M | $219.7M | $744.9M |
Other Health Care Companies
BMY
Bristol Myers Squibb
营收
$12.5B
净利润
$1.1B
JNJ
Johnson & Johnson
营收
$24.6B
净利润
$5.1B
LLY
Lilly (Eli)
营收
$19.3B
净利润
$6.6B
MRK
Merck & Co.
营收
$17.3B
净利润
$5.8B
PFE
Pfizer
营收
$16.7B
净利润
$3.5B
ZTS
Zoetis
营收
$2.4B
净利润
$603.0M
ABT
Abbott Laboratories
营收
$11.4B
净利润
$1.6B
ABBV
AbbVie
营收
$15.8B
净利润
$186.0M
A
Agilent Technologies
营收
$1.9B
净利润
$434.0M
ALGN
Align Technology
营收
$995.7M
净利润
$56.8M